Serum A-FABP is increased and closely associated with elevated NT-proBNP levels in type 2 diabetic patients treated with rosiglitazone (Q34064920)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Serum A-FABP is increased and closely associated with elevated NT-proBNP levels in type 2 diabetic patients treated with rosiglitazone |
scientific article |
Statements
1 reference
Serum A-FABP is increased and closely associated with elevated NT-proBNP levels in type 2 diabetic patients treated with rosiglitazone (English)
1 reference
Mi Zhou
1 reference
Yuqian Bao
1 reference
Junxi Lu
1 reference
Jian Zhou
1 reference
Weiping Jia
1 reference
28 October 2011
1 reference
1 reference
10
1 reference
e27032
1 reference
28 October 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference